> WHO wants to see temperature-resistant vaccines relabeled for use outside of the cold chain. Article
> Seattle BioMed has won a $9.8 million NIH grant for AIDS vaccine development. Release
> Allergy vaccine developer Circassia Pharmaceuticals has raised $333.5 million in its IPO. Piece
> An Indian rotavirus vaccine has been found safe and somewhat effective in a Phase III trial. News
> South Africa has begun providing free HPV vaccination for schoolgirls. Item
> Emergent BioSolutions is to develop vaccines using Valneva's EB66 cell line. Post
> CureVac has won a European innovation prize for work on temperature-resistant vaccines. Piece